Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough.
نویسندگان
چکیده
Affiliations: Service de pneumologie B et transplantation pulmonaire, Hôpital Bichat, APHP, Paris, France. INSERM U1152, Université Paris Diderot-Paris 7, France. Service de pneumologie A, Hôpital Bichat, APHP, Paris, France. Centre d’épidémiologie Clinique, Groupe Hospitalier Cochin – Hôtel Dieu, Paris, France. INSERM U1153, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. National Institute for Health Research Southampton Respiratory Biomedical Research Unit and Clinical and Experimental Sciences, University of Southampton, Southampton, UK.
منابع مشابه
Clinical trials in idiopathic pulmonary fibrosis: update and perspectives
Idiopathic pulmonary fibrosis (IPF) is an increasingly prevalent and devastating disease with high mortality and poor treatment options. Major advances in understanding its underlying pathogenesis have changed the traditional concept of IPF being a chronic inflammatory condition to it being a disordered wound healing and repair process, and have enabled the development of novel therapeutic drug...
متن کاملتحلیل به قصد درمان در مطالعات کارآزمایی بالینی: یک مطالعه مروری
Background & Aim: Randomized controlled trials often suffer from two major problems, i.e., noncompliance and missing outcomes. One potential solution to this problem is using the intention-to-treat (ITT) analysis approach. Therefore, the aim of this study was to review the concept of ITT and the most important issues related to it in practice since RCT researchers utilize it as a guide in order...
متن کاملUpdate on therapeutic management of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive diffuse parenchymal lung disease of unknown origin, with a mortality rate exceeding that of many cancers. The diagnostic process is complex and relies on the clinician integrating clinical, laboratory, radiological, and histological data. In the last decade, major advances in our understanding of the pathogenesis of IPF have shifted ...
متن کاملPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future Perspectives
Idiopathic pulmonary fibrosis (IPF) is a devastating condition with a 5-year survival of approximately 20%. The disease primarily occurs in elderly patients. IPF is a highly heterogeneous disorder with a clinical course that varies from prolonged periods of stability to episodes of rapid deterioration. In the last decade, improved understanding of disease mechanisms along with a more precise di...
متن کاملMethodological issues in trials assessing primary prophylaxis of venous thrombo-embolism.
AIMS Many trials have been conducted to assess the efficacy of various strategies in the prevention of venous thrombo-embolism (VTE). Some of these trials have been subject to methodological criticisms. We aimed to assess the methodological issues raised by VTE trials. METHODS AND RESULTS We searched MEDLINE and the Cochrane Central Register of Controlled Trials for articles assessing primary...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The European respiratory journal
دوره 46 3 شماره
صفحات -
تاریخ انتشار 2015